标题
Hepatitis-B virus: replication cycle, targets, and antiviral approaches
作者
关键词
-
出版物
Current Opinion in Virology
Volume -, Issue -, Pages 101360
出版商
Elsevier BV
发表日期
2023-09-11
DOI
10.1016/j.coviro.2023.101360
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepatitis B
- (2023) Wen-Juei Jeng et al. LANCET
- Hepatitis D Virus Infection
- (2023) Tarik Asselah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
- (2023) Man-Fung Yuen et al. Lancet Gastroenterology & Hepatology
- Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo
- (2022) Cassandra L. Gorsuch et al. MOLECULAR THERAPY
- Safety, tolerability, pharmacokinetics (PK), and antiviral activity of the 3rd generation capsid inhibitor AB-836 in healthy subjects (HS) and subjects with chronic hepatitis B (CHB)
- (2022) Edward J Gane et al. JOURNAL OF HEPATOLOGY
- Hepatitis D virus: Improving virological knowledge to develop new treatments
- (2022) Pierre Khalfi et al. ANTIVIRAL RESEARCH
- Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
- (2022) Man-Fung Yuen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic vaccination for treatment of Chronic Hepatitis B
- (2021) Tamsin Cargill et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The role of N6-methyladenosine modification in the life cycle and disease pathogenesis of hepatitis B and C viruses
- (2021) Geon-Woo Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation
- (2021) João Diogo Dias et al. Viruses-Basel
- Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory
- (2021) Pierre Tonnerre et al. NATURE IMMUNOLOGY
- Mechanism of Hepatitis B Virus cccDNA Formation
- (2021) Lei Wei et al. Viruses-Basel
- Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial
- (2021) Man-Fung Yuen et al. Lancet Gastroenterology & Hepatology
- Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease
- (2021) Patrice Cacoub et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
- (2021) Fanping Meng et al. Hepatology International
- Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection
- (2021) Ed J. Gane et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
- (2020) Michel Bazinet et al. GASTROENTEROLOGY
- JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection
- (2020) Fabien Zoulim et al. GASTROENTEROLOGY
- Hepatitis B Surface Antigen Seroclearance: Immune Mechanisms, Clinical Impact, Importance for Drug Development
- (2020) Issam Tout et al. JOURNAL OF HEPATOLOGY
- Antiviral Activity and Pharmacokinetics of the HBV Capsid Assembly Modulator GLS4 in Patients with Chronic HBV Infection
- (2020) Hong Zhang et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load
- (2019) Anita Schuch et al. GUT
- Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy
- (2019) Anthony Tanoto Tan et al. GASTROENTEROLOGY
- Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
- (2019) Masashi Iwamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic strategies for hepatitis B virus infection: towards a cure
- (2019) Gregory C. Fanning et al. NATURE REVIEWS DRUG DISCOVERY
- Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure
- (2019) Tarik Asselah et al. Lancet Gastroenterology & Hepatology
- Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
- (2019) Man-Fung Yuen et al. Lancet Gastroenterology & Hepatology
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
- (2018) Harry L.A. Janssen et al. JOURNAL OF HEPATOLOGY
- Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
- (2018) Yee Hui Yeo et al. GASTROENTEROLOGY
- Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection
- (2018) Ruben C Hoogeveen et al. GUT
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications
- (2016) Wenhui Li et al. JOURNAL OF HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
- (2015) Edward J. Gane et al. JOURNAL OF HEPATOLOGY
- Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
- (2015) Stephan Menne et al. JOURNAL OF HEPATOLOGY
- GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
- (2013) Robert E. Lanford et al. GASTROENTEROLOGY
- Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection
- (2013) Li-Rung Huang et al. NATURE IMMUNOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Hepatitis B surface antigen seroclearance during chronic HBV infection
- (2010) Chia-Ming Chu et al. ANTIVIRAL THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search